LifeLock 2013 Annual Report Download - page 67
Download and view the complete annual report
Please find page 67 of the 2013 LifeLock annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.
Balance, January 1, 2011 18,541,294 $ 19 $ 12,354 $ – $ (208,494 )$(196,121 )
Stock option exercises 856,207 – 1,752 – – 1,752
Share-based compensation – – 3,285 – – 3,285
Accretion on convertible redeemable
preferred stock – – – – (18,926) (18,926)
Net loss – – – – (4,257) (4,257)
Balance, December 31, 2011 19,397,501 19 17,391 – (231,677 ) (214,267 )
Issuance of stock, net of offering costs 15,500,000 16 125,647 – – 125,663
Stock option and warrant exercises 558,607 1 298 – – 299
Common shares surrendered on net settlement
of option and warrant exercises (215,225 ) – (356) – – (356 )
Share-based compensation – – 6,758 – – 6,758
Accretion on convertible redeemable
preferred stock – – – – (9,378) (9,378)
Beneficial conversion feature – – 2,452 – – 2,452
Accumulated accretion of beneficial
conversion feature – – – – (2,452) (2,452)
Conversion of outstanding convertible
redeemable preferred stock to common stock 51,320,437 51 268,242 – – 268,293
Conversion of outstanding warrants to
purchase convertible redeemable
preferred stock to warrants to purchase
common stock – – 19,451 – – 19,451
Net income – – – – 23,503 23,503
Balance, December 31, 2012 86,561,320 87 439,883 – (220,004 ) 219,966
Stock option and warrant exercises 4,621,091 4 14,670 – – 14,674
Shares purchased under ESPP 107,074 – 819 – – 819
Share-based compensation – – 14,700 – – 14,700
Vesting of restricted stock units 136,886 – – – – –
Restricted stock units surrendered in lieu of
withholding taxes (29,374) – (436 ) – – (436)
Restricted stock issued 44,774 – – – – –
Other comprehensive loss – – – (18 ) – (18)
Net income – – – – 52,451 52,451
Balance, December 31, 2013 91,441,771 $ 91 $ 469,636 $ (18) $ (167,553 )$302,156
See accompanying notes to consolidated financial statements.
64